Injective is gaining attention as investors place greater emphasis on blockchain revenue and valuation metrics. The network says its price-to-sales position ranks fourth among Layer-1 networks, while trading activity, token burns, and expanding financial infrastructure could determine whether Injective can sustain its fundamental growth.
